EFFECTS OF PULMONARY HYPERTENSION ON PULMONARY FUNCTION
Abnormalities of pulmonary function in patients with pulmonary vascular disease are usually a consequence of the underlying lung disease rather than an intrinsic effect of the pulmonary vascular disease. An exception is the decreased diffusing capacity due to capillary obliteration. In addition, pulmonary vascular occlusion and obliteration cause shunt and ventilation-perfusion inequality by undefined mechanisms. The resulting hypoxemia is further exaggerated by the associated reduction of cardiac output and low mixed venous Po2.
- NONMEDICAL MANAGEMENT OF ANGINA PECTORIS
- LIMITATION OF MFARCT SIZE
- PERIPHERAL ANEURYSMS AMD FISTULAE
- PEPTIC ULCER DISEASE OF THE STOMACH AND DUODENUM
- SPECIFIC ARRHYTHMIAS - sinus nodal rhythm disturbances
- CAUSES OF PULMONARY HYPERTENSION
- Pathology
- SYNCOPE
- History and Physical Examination
- GASTROESOPHAGEAL REFLUX DISEASE
- CLINICAL MANIFESTATIONS OF ENDSTAGE RENAL DISEASE
- DISEASES OF THE ESOPHAGUS
- Ultrasound and Computed Tomography
- Therapy
- GENERAL MANAGEMENT OF MYOCARDIAL INFARCTION
- HEPATOCELLULAR CARCINOMA
- Nephrotic Glomerulopathies
- NONOBSTRUCTIVE CAUSES OF ISCHEMIC HEART DISEASE
- PROSTHETIC VALVES
- ORIGIN OF ABDOMINAL PAIN
- Indications for Dialysis and Adequacy of Dialysis
- Other Clearly Extrinsic Causes of Diffuse Infiltrative Lung Disease
- MISCELLANEOUS AORTIC DISEASE
- CLASSIFICATION OF THE MALABSORPTION SYNDROMES
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- CONTROL OF BREATHING IN DISEASE STATES
- RISK FACTORS
- VARIATiT ANGINA
- EMPHYSEMA
- CLINICAL PRESENTATION
- ACUTE PANCREATITIS
- Acid-Base Abnormalities
- Women’s Health Program
- OTHER THERAPEUTIC MODALITIES
- TESTS OF HEPATIC FUNCTION